Rutherford 2 mean change in ldl c levels with evolocumab or placebo biweekly or monthly in hefh
Download
1 / 1

Change from baseline in LDL cholesterol (\%) - PowerPoint PPT Presentation


  • 65 Views
  • Uploaded on

RUTHERFORD-2: mean change in LDL-c levels with evolocumab or placebo biweekly or monthly in HeFH. Change from baseline in LDL cholesterol (%). Raal et al., The Lancet Oct 2014.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Change from baseline in LDL cholesterol (\%)' - dionysus-dale


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Rutherford 2 mean change in ldl c levels with evolocumab or placebo biweekly or monthly in hefh
RUTHERFORD-2: mean change in LDL-c levels with evolocumab or placebo biweekly or monthly in HeFH

Change from baseline in LDL cholesterol (%)

Raal et al., The Lancet Oct 2014